DSM-Firmenich AG (LON: 0AC9)

Market Cap	22.12B
Revenue (ttm)	10.56B
Net Income (ttm)	-159.39M
Shares Out	n/a
EPS (ttm)	-0.60
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	May 9, 2024

Volume	86,381
Average Volume	132,118
Open	98.72
Previous Close	99.03
Day's Range	98.54 - 99.44
52-Week Range	71.42 - 103.54
Beta	n/a
RSI	52.52
Earnings Date	Feb 13, 2025

About DSM-Firmenich AG

DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s...

• Industry: Chemicals and Allied Products
• Founded: 1902
• Employees: 28,685
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0AC9

Financial Performance

In 2023, DSM-Firmenich AG's revenue was 10.63 billion, an increase of 26.66% compared to the previous year's 8.39 billion. Earnings were 2.13 billion, an increase of 25.80%.

Financial numbers in EUR